Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from, 1976. ,
The changing pattern of adult primary glomerular disease, Nephrology Dialysis Transplantation, vol.24, issue.Suppl 2, pp.3050-3054, 2009. ,
DOI : 10.1093/ndt/gfn554
A review of therapeutic studies of idiopathic membranous glomerulopathy, American Journal of Kidney Diseases, vol.25, issue.6, pp.862-875, 1995. ,
DOI : 10.1016/0272-6386(95)90568-5
Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats, Journal of Experimental Medicine, vol.157, issue.2, pp.667-686, 1983. ,
DOI : 10.1084/jem.157.2.667
Antenatal Membranous Glomerulonephritis Due to Anti???Neutral Endopeptidase Antibodies, New England Journal of Medicine, vol.346, issue.26 ,
DOI : 10.1056/NEJMoa012895
Mtype phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy, N ,
URL : https://hal.archives-ouvertes.fr/hal-00417718
Early-Childhood Membranous Nephropathy Due to Cationic Bovine Serum Albumin, New England Journal of Medicine, vol.364, issue.22, pp.2101-2110, 2011. ,
DOI : 10.1056/NEJMoa1013792
The Natural History of the Non-Nephrotic Membranous Nephropathy Patient, Clinical Journal of the American Society of Nephrology, vol.4, issue.9, pp.1417-1422, 2009. ,
DOI : 10.2215/CJN.01330209
Prognosis of Untreated Patients with Idiopathic Membranous Nephropathy, New England Journal of Medicine, vol.329, issue.2, pp.85-89, 1993. ,
DOI : 10.1056/NEJM199307083290203
Spontaneous Remission of Nephrotic Syndrome in Idiopathic Membranous Nephropathy, Journal of the American Society of Nephrology, vol.21, issue.4, pp.697-704, 2010. ,
DOI : 10.1681/ASN.2009080861
Prognostic factors in idiopathic membranous nephropathy, American Journal of Kidney Diseases, vol.31, issue.1, pp.1-11, 1998. ,
DOI : 10.1053/ajkd.1998.v31.pm9428445
Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis, Kidney International, vol.42, issue.4, pp.960-966, 1992. ,
DOI : 10.1038/ki.1992.374
Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications, Kidney International, vol.51, issue.3, pp.901-907, 1997. ,
DOI : 10.1038/ki.1997.127
Urinary excretion of beta 2-microglobulin predicts renal outcome in patients with idiopathic membranous nephropathy, J. Am. Soc. Nephrol. déc, vol.6, issue.6, pp.1666-1669, 1995. ,
Urinary Excretion of ??2-Microglobulin and IgG Predict Prognosis in Idiopathic Membranous Nephropathy: A Validation Study, Journal of the American Society of Nephrology, vol.16, issue.1, pp.169-174, 2005. ,
DOI : 10.1681/ASN.2004040287
Low-Molecular-Weight Proteins as Prognostic Markers in Idiopathic Membranous Nephropathy, Clinical Journal of the American Society of Nephrology, vol.6, issue.12, pp.2846-2853, 2011. ,
DOI : 10.2215/CJN.04020411
Prognostic Value of Risk Score and Urinary Markers in Idiopathic Membranous Nephropathy, Clinical Journal of the American Society of Nephrology, vol.7, issue.8, pp.1242-1248, 2012. ,
DOI : 10.2215/CJN.00670112
Idiopathic membranous nephropathy: Definition and relevance of a partial remission, Kidney International, vol.66, issue.3, pp.1199-1205, 2004. ,
DOI : 10.1111/j.1523-1755.2004.00873.x
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial, The Lancet, vol.377, issue.9784, pp.2181-2192, 2011. ,
DOI : 10.1016/S0140-6736(11)60739-3
Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy, Kidney International, vol.45, issue.2, pp.578-585, 1994. ,
DOI : 10.1038/ki.1994.75
Venous Thromboembolism in Patients with Membranous Nephropathy, Clinical Journal of the American Society of Nephrology, vol.7, issue.1, pp.43-51, 2012. ,
DOI : 10.2215/CJN.04250511
Use of pentoxifylline in membranous nephropathy, The Lancet, vol.357, issue.9269, pp.1672-1673, 2001. ,
DOI : 10.1016/S0140-6736(00)04830-3
Antioxidative Treatment Retards Progression of Idiopathic Membranous Nephropathy, Nephron, vol.86, issue.2, pp.208-209, 2000. ,
DOI : 10.1159/000045751
A Randomized Controlled Trial of Prednisone in Patients with Idiopathic Membranous Nephropathy, New England Journal of Medicine, vol.320, issue.4 ,
DOI : 10.1056/NEJM198901263200403
26 janv, pp.210-215, 1989. ,
Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy, New England Journal of Medicine, vol.310, issue.15 ,
DOI : 10.1056/NEJM198404123101503
A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy, Kidney International, vol.48, issue.5, pp.1600-1604, 1995. ,
DOI : 10.1038/ki.1995.453
A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy, J. Am. Soc. Nephrol. mars, vol.9, issue.3, pp.444-450, 1998. ,
A Randomized, Controlled Trial of Steroids and Cyclophosphamide in Adults with Nephrotic Syndrome Caused by Idiopathic Membranous Nephropathy, Journal of the American Society of Nephrology, vol.18, issue.6, pp.1899-1904, 2007. ,
DOI : 10.1681/ASN.2007020166
Immunosuppression for Membranous Nephropathy: A Systematic Review and Meta-Analysis of 36 Clinical Trials, Clinical Journal of the American Society of Nephrology, vol.8, issue.5, pp.787-796, 2013. ,
DOI : 10.2215/CJN.07570712
Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial, The Lancet, vol.381, issue.9868, pp.744-751, 2013. ,
DOI : 10.1016/S0140-6736(12)61566-9
Tacrolimus monotherapy in membranous nephropathy: A randomized controlled trial, Kidney International, vol.71, issue.9, pp.924-930, 2007. ,
DOI : 10.1038/sj.ki.5002215
Treatment of idiopathic membranous nephropathy with the combination of steroids, tacrolimus and mycophenolate mofetil: results of a pilot study, Nephrology Dialysis Transplantation, vol.22, issue.11, pp.3196-3201, 2007. ,
DOI : 10.1093/ndt/gfm366
Mycophenolate Mofetil Monotherapy in Membranous Nephropathy: A 1-Year Randomized Controlled Trial, American Journal of Kidney Diseases, vol.52, issue.4 ,
DOI : 10.1053/j.ajkd.2008.04.013
Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome, Nephrology, vol.35, issue.6, pp.576-581, 2007. ,
DOI : 10.1093/ndt/gfh312
Mycophenolate Mofetil in Idiopathic Membranous Nephropathy: A Clinical Trial With Comparison to a Historic Control Group Treated With Cyclophosphamide, American Journal of Kidney Diseases, vol.50, issue.2, pp.248-256, 2007. ,
DOI : 10.1053/j.ajkd.2007.05.015
Does immunosuppression with prednisolone and azathioprine alter the progression of idiopathic membranous nephropathy?, American Journal of Kidney Diseases, vol.34, issue.3, pp.521-529, 1999. ,
DOI : 10.1016/S0272-6386(99)70081-8
Rituximab for idiopathic membranous nephropathy, The Lancet, vol.360, issue.9337, pp.923-924, 2002. ,
DOI : 10.1016/S0140-6736(02)11042-7
Rituximab in Idiopathic Membranous Nephropathy: A One-Year Prospective Study, Journal of the American Society of Nephrology, vol.14, issue.7, pp.1851-1857, 2003. ,
DOI : 10.1097/01.ASN.0000071511.35221.B3
Rituximab treatment of idiopathic membranous nephropathy, Kidney International, vol.73, issue.1, pp.117-125, 2008. ,
DOI : 10.1038/sj.ki.5002628
Successful Treatment of Membranous Glomerulonephritis with Rituximab in Calcineurin Inhibitor-Dependent Patients, Clinical Journal of the American Society of Nephrology, vol.4, issue.6, pp.1083-1088, 2009. ,
DOI : 10.2215/CJN.06041108
Efficacy and Safety of Rituximab Second-Line Therapy for Membranous Nephropathy: A Prospective, Matched-Cohort Study, American Journal of Nephrology, vol.5, issue.5, pp.461-468, 2011. ,
DOI : 10.2215/CJN.05080610
Rituximab in Idiopathic Membranous Nephropathy, Journal of the American Society of Nephrology, vol.23, issue.8, pp.1416-1425, 2012. ,
DOI : 10.1681/ASN.2012020181
A Randomized Pilot Trial Comparing Methylprednisolone Plus a Cytotoxic Agent Versus Synthetic Adrenocorticotropic Hormone in Idiopathic Membranous Nephropathy, American Journal of Kidney Diseases, vol.47, issue.2, pp.233-240, 2006. ,
DOI : 10.1053/j.ajkd.2005.10.016
Management of idiopathic membranous nephropathy: Evidence-based recommendations, Kidney International, vol.55, pp.47-55, 1999. ,
DOI : 10.1046/j.1523-1755.1999.07007.x
The treatment of idiopathic membranous nephropathy: A dilemma or a conundrum?, American Journal of Kidney Diseases, vol.44, issue.3, pp.562-566, 2004. ,
DOI : 10.1016/S0272-6386(04)00868-6
Idiopathic Membranous Nephropathy: Outline and Rationale of a Treatment Strategy, American Journal of Kidney Diseases, vol.46, issue.6, pp.1012-1029, 2005. ,
DOI : 10.1053/j.ajkd.2005.08.020
Management of patients with membranous nephropathy, Nephrology Dialysis Transplantation, vol.25, issue.1 ,
DOI : 10.1093/ndt/gfp390
The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines???application to the individual patient, Kidney International, vol.82, issue.8, pp.840-856, 2012. ,
DOI : 10.1038/ki.2012.280
Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial, Nephrology Dialysis Transplantation, vol.56, issue.4, pp.129-136, 2010. ,
DOI : 10.1159/000186178
Prognosis of idiopathic membranous nephropathy: A methodologic meta-analysis, Kidney International, vol.51, issue.3, pp.873-879, 1997. ,
DOI : 10.1038/ki.1997.123
Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: A nationwide survey in the Netherlands, Nephrology Dialysis Transplantation, vol.74, issue.274, pp.3534-3538, 2008. ,
DOI : 10.1056/NEJM198901263200403
Outcome of idiopathic membranous nephropathy using targeted stepwise immunosuppressive treatment strategy, Nephrology Dialysis Transplantation, vol.65, issue.4, pp.2871-2877, 2011. ,
DOI : 10.1111/j.1523-1755.2004.00518.x
Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy, Nephrology Dialysis Transplantation, vol.50, issue.3, pp.235-242, 2012. ,
DOI : 10.1053/j.ajkd.2007.06.003
Why Don't Physicians Follow Clinical Practice Guidelines? A Framework for Improvement, Pediatric Research, vol.45, issue.4, Part 2 of 2, pp.1458-1465, 1999. ,
DOI : 10.1203/00006450-199904020-00719
Individual and collective facilitators of and barriers to the use of clinical practice guidelines by physicians: a literature review, Rev Epidemiol Sante Publique. févr, vol.51, issue.1, pp.65-80, 2003. ,